Resources
Reports, Whitepapers & Articles

Report
How Early Patient Journey Challenges Influence Long-Term Adherence
Long-term adherence challenges often take shape when patients are still trying to understand what comes next, where to turn, and how to move forward. The June 2026 Patient Services Report explores why the earliest stages of the patient journey deserve greater focus, and how more connected patient engagement can help improve continuity across the treatment experience.

Report
Meeting Patients Where They Are: Education That Builds Confidence
Our May Patient Services Report explores how trust, clarity, and connection shape sustained patient engagement. Sustained engagement isn't built on one-off interactions. It's built on these three things over time, and they shape whether patients stay engaged throughout their journey. This report examines the strategies pharma can use to better support patients and keep them engaged. Explore what keeps patients engaged throughout their journey.

Report
2026 Asembia Insights and Takeaways
Pricing policy is reshaping program design. Agentic AI is transforming operations. PBM transparency is raising the bar on proving value. And human connection still drives adherence where technology falls short. Momentum Life Sciences breaks down five insights that capture where patient support is headed — and what it takes to keep up. Read the full recap.

Report
Hub East 2026 – Patient Engagement Insights
Explore insights and key takeaways from Hub and Specialty Pharmacy East 2026. Inside, we highlight the biggest themes shaping patient and HCP engagement—smarter front-end experience design, measurable outcomes, and the enduring importance of human connection in high-touch moments. Discover why industry leaders are talking about these perspectives and how they apply to real support programs.
Presentations & Webinars

Webinar
Beyond the Numbers: Demonstrating Hub Model Value in Specialty and Rare Disease Patient Support
Join Josh Konetzni and Melissa Beatty to explore evaluating hub models for adherence, outcomes, and demonstrating patient support value in complex therapies.

Webinar
Adherence Challenges in Rare and Specialty
Up to 65% of rare disease patients stop medication, half within a year. This segment of our latest webinar reveals adherence challenges and how personalized support boosts persistency by 61%, maximizing therapy value.

Webinar
Hub Model Evolution and Types
Explore the evolution of pharma hub models, from basic access to complex patient engagement. Rising drug costs and patient needs drive today's hybrid models, combining insourced control with outsourced expertise for flexible, data-driven, personalized care.

Webinar
Adapting to Shifting Market Dynamics
Pharma's changing: patent expirations and new therapies reshape patient support. Flexible hybrid hubs are essential for agility, investment, and engagement. Future-proof your strategy.
Blog
Meeting Patients Where They Are: Why Trust Matters
Patient support programs have steadily expanded , adding more channels, more touchpoints, and more digital tools designed to keep patients informed and on therapy. But the experience patients describe often tells a different story. Despite the investments in personalization tools, channel optimization, and deep analytics around engagement, many patients report feeling less connected to their support program over time, not more.
The Front-End Shift: Prioritizing Dedicated Patient Engagement Beyond Hub and Specialty Pharmacy
Much of today's patient support is structured around the prescription — access, fulfillment, logistics. But some of the moments that most influence whether a patient initiates, adheres, and persists tend to happen somewhere else entirely: in the space between the prescription and the patient.
Case Studies
Press Releases
Momentum Life Sciences Announces Strategic Growth Investment from Parthenon Capital
Momentum Life Sciences (“Momentum” or the “Company”), a leading commercialization platform offering patient- and provider-facing solutions that support initiation and adherence for specialty therapies, announced a strategic investment from Parthenon Capital, a growth-oriented private equity firm with a long history of supporting innovative companies in healthcare solutions and technology.
PM360 Names Momentum’s Jillian Keczkemethy as 2026 ELITE 100 Patient Experience Architect
INDIANAPOLIS – May 13, 2026 – Momentum Life Sciences proudly announces that Jillian Keczkemethy, Director of Client Solutions, has been selected for the prestigious 2026 ELITE 100 by PM360 in the Patient Experience Architect category for her exceptional contributions to patient support and engagement.
Momentum Life Sciences Announces 2026 Impact Award Winners
Indianapolis, Indiana – May 6, 2026 — During this year’s National Nurses Week celebration, Momentum Life Sciences presented its annual Impact Awards to three outstanding individuals: Tonja Guthrie, Virtual Nurse Educator, Aimee Johnson, Case Manager and Shari Mott, Field Nurse Educator.
Momentum Life Sciences Named One of America’s Top 100 Most Loved Workplaces® for 2025 — Ranking #30
Indianapolis, IN - October 21, 2025 - Momentum Life Sciences, a leader in patient engagement solutions, has been named one of the 2025 America’s Top 100 Most Loved Workplaces®, ranking #30 among companies nationwide.











